MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ebele M Umeukeje, MD, MPH
Vanderbilt University Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Davita Philadelphia Pmc Dialysis
Philadelphia, Pennsylvania, United States
- Davita University City Dialysis
Philadelphia, Pennsylvania, United States
- Buttonwood Davita Dialysis 449 N Broad St,
Philadelphia, PA 19123, Pennsylvania, United States
- Dialysis Clinic, Inc.
Nashville, Tennessee, United States
- Vanderbilt Dialysis Clinic
Nashville, Tennessee, United States
- Vanderbilt Dialysis Clinic East
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Oct 2023
- Primary completion
- 1 Nov 2027
- Completion
- 1 Nov 2027
- Last update posted
- 23 Apr 2026
- Registered enrollment
- 176
- Registry id
- NCT05735743
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.